Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982 Nov;57(11):864-6.
doi: 10.1136/adc.57.11.864.

Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler

H V Field, P M Jenkinson, M H Frame, J O Warner
Clinical Trial

Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler

H V Field et al. Arch Dis Child. 1982 Nov.

Abstract

In a double-blind crossover trial a new corticosteroid aerosol, budesonide, delivered by spacer inhaler twice daily, was found to be at least as effective in controlling childhood asthma as beclomethasone dipropionate administration four times a day. The twice daily dosage schedule of the new preparation offers considerable advantages for compliance with therapy in schoolchildren. Previous studies have shown that lung deposition of aerosol is increased by the use of a tube spacer between the pressurised aerosol inhaler and the mouth. This technique of administration may improve the efficacy of corticosteroids in the treatment of asthma.

PubMed Disclaimer

References

    1. J Appl Physiol. 1969 Mar;26(3):308-16 - PubMed
    1. J Allergy Clin Immunol. 1971 Dec;48(6):344-54 - PubMed
    1. Acta Paediatr Scand. 1975 Mar;64(2):234-40 - PubMed
    1. Aust Fam Physician. 1980 Oct;9(10):721-6 - PubMed
    1. Lancet. 1980 Dec 6;2(8206):1248 - PubMed

MeSH terms

LinkOut - more resources